565 related articles for article (PubMed ID: 8246174)
1. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
Vinh DB; McIvor RS
J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
[TBL] [Abstract][Full Text] [Related]
2. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
[TBL] [Abstract][Full Text] [Related]
3. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
James RI; May C; Vagt MD; Studebaker R; McIvor RS
Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow.
Belur LR; Boelk-Galvan D; Diers MD; McIvor RS; Zimmerman CL
Cancer Res; 2001 Feb; 61(4):1522-6. PubMed ID: 11245460
[TBL] [Abstract][Full Text] [Related]
6. Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.
Zhao SC; Li MX; Banerjee D; Schweitzer BI; Mineishi S; Gilboa E; Bertino JR
Cancer Gene Ther; 1994 Mar; 1(1):27-33. PubMed ID: 7621235
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
[TBL] [Abstract][Full Text] [Related]
9. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
[TBL] [Abstract][Full Text] [Related]
10. Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.
McIvor RS
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S50-4. PubMed ID: 8971409
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
Mineishi S; Nakahara S; Takebe N; Banerjee D; Zhao SC; Bertino JR
Gene Ther; 1997 Jun; 4(6):570-6. PubMed ID: 9231073
[TBL] [Abstract][Full Text] [Related]
12. [Double-mutant dihydrofolate reductase gene transfection into bone marrow cells protects mice from chemotherapy].
Gao HD; Lu P; Lu Y; Pang K; Xu HM; Wang SB; Chen JQ; Zhao SC
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):583-5. PubMed ID: 17236551
[TBL] [Abstract][Full Text] [Related]
13. [Insertion of the bacterial gene for dihydrofolate reductase into colony-forming cells of mouse bone marrow].
Titomirov AV; Pereverzev AE; Stepan'ian LI; Podgornaia OI; Aprelikova ON
Tsitologiia; 1985 Oct; 27(10):1183-8. PubMed ID: 3000033
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase.
Gori JL; Podetz-Pedersen K; Swanson D; Karlen AD; Gunther R; Somia NV; McIvor RS
J Pharmacol Exp Ther; 2007 Sep; 322(3):989-97. PubMed ID: 17586722
[TBL] [Abstract][Full Text] [Related]
15. In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease.
Havenga M; Valerio D; Hoogerbrugge P; Es H
Gene Ther; 1999 Oct; 6(10):1661-9. PubMed ID: 10516714
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation.
James R; May C; Diers M; Wagner J; McIvor R
Bone Marrow Transplant; 1999 Oct; 24(8):815-21. PubMed ID: 10516690
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.
May C; James RI; Gunther R; McIvor RS
J Pharmacol Exp Ther; 1996 Sep; 278(3):1444-51. PubMed ID: 8819532
[TBL] [Abstract][Full Text] [Related]
18. Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistance.
Braun SE; McIvor RS; Davidson AS; Hanna M; Traycoff CM; Berebetsky DA; Gonin R; Broxmeyer HE; Cornetta K
Cancer Gene Ther; 1997; 4(1):26-32. PubMed ID: 9012448
[TBL] [Abstract][Full Text] [Related]
19. Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.
Banerjee D; Zhao SC; Tong Y; Steinherz J; Gritsman K; Bertino JR
Cancer Gene Ther; 1994 Sep; 1(3):181-4. PubMed ID: 7621249
[TBL] [Abstract][Full Text] [Related]
20. Myeloproliferative sarcoma virus directed expression of beta-galactosidase following retroviral transduction of murine hematopoietic cells.
Clapp DW; Freie B; Srour E; Yoder MC; Fortney K; Gerson SL
Exp Hematol; 1995 Jul; 23(7):630-8. PubMed ID: 7601255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
